Anticancer Ruthenium Complexes with HDAC Isoform Selectivity
- Supplementary File 1:
PDF-Document (PDF, 4067 KiB)
Cross, J.M.; Blower, T.R.; Kingdon, A.D.H.; Pal, R.; Picton, D.M.; Walton, J.W. Anticancer Ruthenium Complexes with HDAC Isoform Selectivity. Molecules 2020, 25, 2383. https://doi.org/10.3390/molecules25102383
Cross JM, Blower TR, Kingdon ADH, Pal R, Picton DM, Walton JW. Anticancer Ruthenium Complexes with HDAC Isoform Selectivity. Molecules. 2020; 25(10):2383. https://doi.org/10.3390/molecules25102383
Chicago/Turabian StyleCross, Jasmine M., Tim R. Blower, Alexander D. H. Kingdon, Robert Pal, David M. Picton, and James W. Walton. 2020. "Anticancer Ruthenium Complexes with HDAC Isoform Selectivity" Molecules 25, no. 10: 2383. https://doi.org/10.3390/molecules25102383